Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
PTT Global Chemical Q2 adjusted EBITDA rises 81% q/q to THB 26.93 billion

PTT Global Chemical Q2 adjusted EBITDA rises 81% q/q to THB 26.93 billion

ReutersReuters2026/08/11 03:22
  • PTT Global Chemical posted Q2 2026 adjusted EBITDA of THB 26.93 billion, up 81% quarter-on-quarter; net profit rose to THB 12.21 billion.
  • H1 2026 adjusted EBITDA totaled THB 41.78 billion; net profit came in at THB 15.44 billion.
  • Ethane import project from the U.S. stays on track, with imports scheduled to begin in 2029.
  • Set a 2026 target of THB 4 billion in added revenue and cost cuts, following more than THB 7 billion in benefits in 2025.
  • CEO Narongsak Jivakanun said GC is strengthening resilience while accelerating Specialty and Green & Bio to build a higher-value, lower-carbon portfolio.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. PTT Global Chemical pcl published the original content used to generate this news brief on August 10, 2026, and is solely responsible for the information contained therein.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Electra Therapeutics Inc. has officially filed for an initial public offering (IPO), aiming to leverage the strong IPO performance of the biotechnology sector this year to raise funds for its clinical-stage pipeline of drugs targeting immune-mediated diseases and cancer.

智通财经2026/08/29 03:22
Electra Therapeutics (ETRA.US) submits US IPO application, leveraging the biotech IPO boom to advance new drug development for immune diseases and cancer.

Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)

A $2.4 billions debt financing round, led by funds under Blue Owl Capital Inc., has been finalized. The funds will be allocated to cloud service provider IREN Ltd. to purchase NVIDIA's Blackwell Ultra GPUs, supporting the development of its data center campus in Canada.

智通财经2026/08/29 02:27
Blue Owl (OWL.US) teams up with PIMCO to tailor a $2.4 billion GPU financing for IREN (IREN.US)